Among the various subtypes of breast cancer, hormone receptor (HR) positive (+), human epidermal growth factor receptor 2 negative (HER2-) breast cancer accounts for the majority (68%) of all cases (2). This evidence concerns the gene ERBB2 and breast carcinoma.